Predicting the prognosis of breast cancer patients by using nutrition-based index: a systematic review and meta-analysis
Prognose von Brustkrebs-Patient:innen mit einem ernährungsbasierten Index vorhersagen: systematische Übersicht und Metaanalyse
Frontiers in Oncology · 11.05.2026 · 16
DOI: 10.3389/fonc.2026.1775719 ↗Auf einen Blick
32 Studien mit 13.120 Patient:innen mit Brustkrebs: Höhere PNI-Werte waren mit besserem OS und DFS verbunden, höhere CONUT-Werte mit schlechterem OS und DFS.
Fragestellung
Wie gut sagen PNI und CONUT klinische Outcomes bei Brustkrebs voraus?
Methode
Systematische Übersicht und Metaanalyse; Suche in PubMed, Embase, Web of Science und Cochrane Library bis 20. Oktober 2025.
Ergebnisse
32 Berichte mit 13.120 Personen. Höherer PNI: OS HR 0,49 (95 %-KI 0,39–0,61), DFS HR 0,69 (95 %-KI 0,58–0,81), pCR OR 1,57 (95 %-KI 1,00–2,47). Höherer CONUT: OS HR 1,77 (95 %-KI 1,29–2,44), DFS HR 2,08 (95 %-KI 1,75–2,47).
Einschränkungen
Die Prognoseintervalle für PNI und OS/DFS/pCR sowie CONUT und OS kreuzten den Nullwert; zwischen den Studien bestand deutliche Variabilität.
Schlussfolgerung der Autor:innen
Nach Einschätzung der Autor:innen waren höhere PNI-Werte mit besserem OS und DFS verbunden, höhere CONUT-Werte mit schlechterem OS und DFS. PNI und CONUT könnten prognostische Marker bei Brustkrebs sein.
Kernaussagen
- PNI: höher mit besserem OS und DFS assoziiert
- CONUT: höher mit schlechterem OS und DFS assoziiert
- pCR für PNI war nicht eindeutig; Ergebnisse heterogen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 11.05.2026. Verfasst von Si Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Clinical Medical Research Center of Breast and Thyroid Tumor in Xinjiang, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The prognostic nutritional index (PNI) and the controlling nutritional status (CONUT) score are composite markers of nutritional and inflammatory status that are used to predict tumor progression. Their prognostic relevance in breast cancer (BC) has been reported, but the evidence remains inconsistent. Therefore, the prognostic utility of PNI and CONUT in BC was evaluated in this meta-analysis.
Methods
A search was carried out across four major databases: PubMed, Embase, Web of Science, and the Cochrane Library, from inception to 20 October 2025. Studies assessing the association of PNI or CONUT with clinical outcomes in BC were included based on prespecified eligibility criteria. Overall survival (OS), disease-free survival (DFS), and pathological complete response (pCR) were analyzed, and pooled effects were reported as hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs). Subgroup analyses, meta-regression, and 95% prediction intervals (PIs) were used to explore heterogeneity.
Results
A total of 32 reports comprising 13,120 individuals with BC were included. Higher PNI was linked with improved OS (HR = 0.49, 95% CI 0.39-0.61; P < 0.00001; I² = 83%) and longer DFS (HR = 0.69, 95% CI 0.58-0.81; P < 0.00001; I² = 83%), whereas the evidence for an association between PNI and pCR was inconclusive (OR = 1.57, 95% CI 1.00-2.47; P = 0.05; I² = 83%), and the result was sensitive to individual studies. In addition, higher CONUT corresponded to poorer OS (HR = 1.77, 95% CI 1.29-2.44; P = 0.0005; I² = 77%) and shorter DFS (HR = 2.08, 95% CI 1.75-2.47; P < 0.00001; I² = 6%). Prediction intervals for PNI and OS, PNI and DFS, PNI and pCR, and CONUT and OS all crossed the null value, indicating substantial between-study variability in the expected effect across future settings.
Conclusions
Across the included studies, higher PNI was associated with better OS and DFS, while elevated CONUT was associated with poorer OS and DFS. Therefore, PNI and CONUT may be considered candidate prognostic indicators in BC.
Systematic review registration
PROSPERO, identifier CRD420251249070.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Clinical Medical Research Center of Breast and Thyroid Tumor in Xinjiang, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi, China.
- Medical Imaging Center, Cancer Hospital Affiliated to Xinjiang Medical University, Urumqi, China.
Zitieren
APA
Chen, S., Miao, J., Cheng, X., & Duan, Y. (2026). Predicting the prognosis of breast cancer patients by using nutrition-based index: a systematic review and meta-analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1775719
Vancouver
Chen S, Miao J, Cheng X, Duan Y. Predicting the prognosis of breast cancer patients by using nutrition-based index: a systematic review and meta-analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1775719
BibTeX
@article{Chen2026,
author = {Chen, Si and Miao, Jun and Cheng, Xin and Duan, Yan},
title = {Predicting the prognosis of breast cancer patients by using nutrition-based index: a systematic review and meta-analysis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1775719}
}
EUVIMED